On March 19, 2024, Elicio Therapeutics, Inc closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | -0.27% | -10.71% | -56.00% |
Jul. 01 | Elicio Therapeutics, Inc.(NasdaqGM:ELTX) added to Russell Microcap Growth Index | CI |
Jul. 01 | Elicio Therapeutics, Inc.(NasdaqGM:ELTX) added to Russell 3000E Index | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.00% | 37.74M | |
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
+31.15% | 31.46B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- ELTX Stock
- News Elicio Therapeutics, Inc.
- Elicio Therapeutics, Inc. announced that it has received $5.999999 million in funding from Gkcc, LLC